跳至主要内容
临床试验/NCT01844388
NCT01844388已完成3 期

A Study to Compare a New Eye Drop Formulation With Refresh Contacts®

Allergan0 个研究点目标入组 365 人开始时间: 2013年5月29日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
Allergan
入组人数
365
主要终点
Percentage of Participants With Contact Lens Distance Visual Acuity Change From Baseline

研究概览

简要总结

This study will compare the safety and efficacy of a new carboxymethylcellulose based eye drop formula to Refresh Contacts® for lubricating and rewetting contact lenses.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adapted contact wearer with daily usage of at least 6 hours a day, 5 days a week.

排除标准

  • Wearing monovision lenses
  • Have had refractive surgery within the previous 12 months
  • Have infection of the eye, eyelids or eye structures.

研究组 & 干预措施

Carboxymethylcellulose Based Eye Drop Formula

Experimental

1-2 drops of carboxymethylcellulose based eye drop formula in each eye, a minimum of 4 times a day for 90 days. One of the 4 times a day may be to prepare the contact lens for insertion.

干预措施: carboxymethylcellulose based eye drop formula (Drug)

REFRESH CONTACTS®

Active Comparator

1-2 drops carboxymethylcellulose sodium based eye drop solution (REFRESH CONTACTS®) in each eye, a minimum of 4 times a day for 90 days. One of the 4 times a day may be to prepare the contact lens for insertion.

干预措施: carboxymethylcellulose sodium based eye drop solution (Drug)

结局指标

主要结局

Percentage of Participants With Contact Lens Distance Visual Acuity Change From Baseline

时间窗: Baseline, Day 90

Contact lens distance visual acuity was measured for each eye using the LogMAR visual acuity eye chart. The worse eye at Baseline was used for analysis. A change of 0.1 on the LogMAR scale was equivalent to a 1 line change in visual acuity. The following categories are reported: Better=an increase in 2 or more lines, No Change=a change of +/- 1 line, and Worse=a decrease of 2 lines or more.

次要结局

未报告次要终点

研究者

发起方
Allergan
申办方类型
Industry
责任方
Sponsor

相似试验

A Study to Compare a New Eye Drop Formulation With... | 临床试验